Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

April W Armstrong

Showing results (381-390 of 434) with videos related to

Pageof 44
Sort By:
The Journal of Dermatological Treatment|March 12, 2026
Lebrikizumab off-therapy remission sustained up to 38 weeks in atopic dermatitisJonathan I Silverberg, Thomas Bieber, Kilian Eyerich, et al.
Acta Dermato-Venereologica|March 12, 2024
Correlation between Dermatology Life Quality Index and Psoriasis Area and Severity Index in Patients with Psoriasis: A Cross-sectional Global Healthcare Study on PsoriasisJulia-Tatjana Maul, Lara V Maul, Johannes A Didaskalu, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|March 6, 2025
Deucravacitinib in plaque psoriasis: Four-year safety and efficacy results from the Phase 3 POETYK PSO-1, PSO-2 and long-term extension trialsApril W Armstrong, Mark Lebwohl, Richard B Warren, et al.
Dermatology and Therapy|June 8, 2018
Building a Citizen Pscientist: Advancing Patient-Centered Psoriasis Research by Empowering Patients as Contributors and AnalystsIsabelle M Sanchez, Lindsey Shankle, Marilyn T Wan, et al.
Life (Basel, Switzerland)|October 26, 2024
Global Comparison of COVID-19 Vaccination Rates among Psoriasis PatientsEdwin Korouri, Charlotte Jeong, Hannah Peterson, et al.
Journal of the American Academy of Dermatology|June 5, 2019
Patient-reported outcomes of adalimumab, phototherapy, and placebo in the Vascular Inflammation in Psoriasis Trial: A randomized controlled studyMegan H Noe, Marilyn T Wan, Daniel B Shin, et al.
JAMA Dermatology|May 15, 2026
Ixekizumab With or Without Tirzepatide in Adults With Psoriasis and Overweight or Obesity: A Phase 3b Randomized Clinical TrialMark Lebwohl, Andrew Blauvelt, Cynthia E Kartman, et al.
The Journal of Rheumatology. Supplement|June 3, 2020
Proceedings of the 2019 GRAPPA Collaborative Research Network MeetingRobin Waxman, Carmel Stober, Deepak R Jadon, et al.
Dermatology (Basel, Switzerland)|September 19, 2021
International Dermatology Outcome Measures (IDEOM): Report from the 2020 Annual MeetingAlison H Kohn, Afsaneh Alavi, April W Armstrong, et al.
The Journal of Rheumatology. Supplement|June 2, 2021
Proceedings of the 2020 GRAPPA Collaborative Research Network (CRN) MeetingCarmel Stober, Deepak R Jadon, April W Armstrong, et al.
Pageof 44

Showing results (381-390 of 434) with videos related to

Sort By:
Pageof 44
The Journal of Dermatological Treatment|March 12, 2026
Lebrikizumab off-therapy remission sustained up to 38 weeks in atopic dermatitisJonathan I Silverberg, Thomas Bieber, Kilian Eyerich, et al.
Acta Dermato-Venereologica|March 12, 2024
Correlation between Dermatology Life Quality Index and Psoriasis Area and Severity Index in Patients with Psoriasis: A Cross-sectional Global Healthcare Study on PsoriasisJulia-Tatjana Maul, Lara V Maul, Johannes A Didaskalu, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|March 6, 2025
Deucravacitinib in plaque psoriasis: Four-year safety and efficacy results from the Phase 3 POETYK PSO-1, PSO-2 and long-term extension trialsApril W Armstrong, Mark Lebwohl, Richard B Warren, et al.
Dermatology and Therapy|June 8, 2018
Building a Citizen Pscientist: Advancing Patient-Centered Psoriasis Research by Empowering Patients as Contributors and AnalystsIsabelle M Sanchez, Lindsey Shankle, Marilyn T Wan, et al.
Life (Basel, Switzerland)|October 26, 2024
Global Comparison of COVID-19 Vaccination Rates among Psoriasis PatientsEdwin Korouri, Charlotte Jeong, Hannah Peterson, et al.
Journal of the American Academy of Dermatology|June 5, 2019
Patient-reported outcomes of adalimumab, phototherapy, and placebo in the Vascular Inflammation in Psoriasis Trial: A randomized controlled studyMegan H Noe, Marilyn T Wan, Daniel B Shin, et al.
JAMA Dermatology|May 15, 2026
Ixekizumab With or Without Tirzepatide in Adults With Psoriasis and Overweight or Obesity: A Phase 3b Randomized Clinical TrialMark Lebwohl, Andrew Blauvelt, Cynthia E Kartman, et al.
The Journal of Rheumatology. Supplement|June 3, 2020
Proceedings of the 2019 GRAPPA Collaborative Research Network MeetingRobin Waxman, Carmel Stober, Deepak R Jadon, et al.
Dermatology (Basel, Switzerland)|September 19, 2021
International Dermatology Outcome Measures (IDEOM): Report from the 2020 Annual MeetingAlison H Kohn, Afsaneh Alavi, April W Armstrong, et al.
The Journal of Rheumatology. Supplement|June 2, 2021
Proceedings of the 2020 GRAPPA Collaborative Research Network (CRN) MeetingCarmel Stober, Deepak R Jadon, April W Armstrong, et al.
Pageof 44